Coronavirus updates: Barron Trump also tested positive for COVID, Melania says

Melania Trump said she and her son have now tested negative.

A pandemic of the novel coronavirus has now killed more than 1 million people worldwide.

Over 38.4 million people across the globe have been diagnosed with COVID-19, the disease caused by the new respiratory virus, according to data compiled by the Center for Systems Science and Engineering at Johns Hopkins University. The criteria for diagnosis -- through clinical means or a lab test -- has varied from country-to-country. Still, the actual numbers are believed to be much higher due to testing shortages, many unreported cases and suspicions that some national governments are hiding or downplaying the scope of their outbreaks.

The United States is the worst-affected country, with more than 7.9 million diagnosed cases and at least 216,639 deaths.

California has the most cases of any U.S. state, with more than 865,000 people diagnosed, according to Johns Hopkins data. California is followed by Texas and Florida, with over 830,000 cases and over 741,000 cases, respectively.

More than 190 vaccine candidates for COVID-19 are being tracked by the World Health Organization, at least 10 of which are in crucial phase three studies. Of those 10 potential vaccines in late-stage trials, there are currently five that will be available in the United States if approved.


0

'Herd immunity' is not the answer for solving the pandemic, officials say

Promoting the concept of "herd immunity" or "community immunity," a form of indirect protection from infectious disease that occurs when a certain percentage of a population has become immune, is "inappropriate, irresponsible and ill-informed," Thomas M. File Jr., president of the Infectious Diseases Society of America, announced in a statement Wednesday.

While the concept is the goal of vaccination campaigns, it "should never come at the cost of the planned exposure and infection of millions of additional people," File said.

ABC News' Eric Strauss contributed to this report.


Russia prepares to test 2nd COVID-19 vaccine on 40,000 volunteers

Russia has registered a second COVID-19 vaccine and is preparing to test it on 40,000 volunteers, according to Russian officials.

The vaccine, called "EpiVakKorona," was produced by the 'Vector' State Research Center of Virology and Biotechnology in Novosibirsk, a top state lab that since Soviet times has also been a key biological warfare center.

Unlike the first vaccine, Sputnik V, the new vaccine is not based on a modified adenovirus but instead is a "peptide" type vaccine that uses artificially synthesized fragments of the coronavirus itself to produce an immune response. It is administered in two doses, 21 days apart, according to Russian news agency TASS.

Caution must be used when giving it to patients suffering from chronic kidney and liver illnesses, as well as epilepsy and heart illnesses, TASS reported.

So far the vaccine has been tested on about 100 people, but it has not yet passed key clinical trials. The vaccine will now undergo, in effect, a phase 3 trial.

Sputnik V could be widely distributed in Russia by late October or early November, head of the Russian Direct Investment Fund Kirill Dmitriev announced on Monday, according to TASS.

A third Russian vaccine is also on the way -- produced by the M.P. Chumakov Federal Scientific Center for Research and Development of Immuno-biological Drugs, Russian President Vladimir Putin announced Wednesday. A phase 3 trial for that vaccine will begin Monday.

ABC News’ Patrick Reevell contributed to this report.


Funding to be withheld for New York schools in 'red zones'

New York Gov. Andrew Cuomo will withhold funding from schools in "red zones" that remain open –- both public and private –- until matters are resolve to the states liking, Cuomo announced during a conference call Wednesday.

Just over 1,200 people tested positive and seven people died in the state on Tuesday, Cuomo said. The test positivity rate in the "red zone" areas is 6.2%, while the statewide positivity rate excluding Red Zones is .95%.

ABC News’ J. Gabriel Ware contributed to this report.


Trump seeking emergency approval for Regeneron

President Donald Trump is working to get emergency approval for Regeneron, the antibody treatment that he himself received after contracting COVID-19.

The treatment made him "feel very good very fast," he told reporters from the Rose Garden of the White House on Wednesday morning.

"They call it a therapeutic, but I don't think it was therapeutic," Trump said. "I think it was a cure. For me, it was something that was very good. Who knows, maybe it would have happened anyway, maybe I would have recovered beautifully anyway. All I know is once I had Regeneron it worked out very well."


Brigham Young University-Idaho probing reports of students intentionally contracting COVID-19 to sell plasma

Brigham Young University-Idaho said it is investigating reports of students who have intentionally exposed themselves or others to COVID-19 with the hope of getting the disease and being paid for plasma that contains antibodies.

The private university in Rexburg, Idaho, shared the development in a statement posted on its website Monday, saying it was "deeply troubled" by the accounts.

"The university condemns this behavior and is actively seeking evidence of any such conduct among our student body," the school said. "Students who are determined to have intentionally exposed themselves or others to the virus will be immediately suspended from the university and may be permanently dismissed."

The university warned that it may be forced to transition to a fully-remote instruction model if recent COVID-19 trends in surrounding Madison County and across Idaho continue.

"The contraction and spread of COVID-19 is not a light matter. Reckless disregard for health and safety will inevitably lead to additional illness and loss of life in our community," the school said. "We urge all members of the campus community to act respectfully and responsibly by observing all public health and university protocols and placing the well-being of others above personal benefit or convenience."

The university added that it "stands ready to help" students who are struggling with the physical, emotional and financial strain of the coronavirus pandemic.

"There is never a need to resort to behavior that endangers health or safety in order to make ends meet," the school said.

At least 109 students and 22 employees at Brigham Young University-Idaho have contracted COVID-19, according to the latest data provided by the school.

ABC News' Jon Haworth contributed to this report.